Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
William H. Rastetter
AddedMar 31, 2024
UpdatedMay 31, 2026
William H. Rastetter

William H. Rastetter

Board Member, Daré Bioscience

Crunchbase

William H. Rastetter's Career

Daré Bioscience
Daré Bioscience

San Diego, CA, US

Board Member· Board
Regulus Therapeutics
Regulus Therapeutics

San Diego, CA, US

Board Member· Board
Neurocrine B
Neurocrine B

San Diego, CA, US

Board Member· Board
GRAIL
GRAIL

Menlo Park, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

William H. Rastetter's Career

Daré Bioscience
Daré Bioscience
Public$22.1M332005San Diego, CA, US
Board Member· Board

Leadership at Daré Bioscience

Susan KelleySusan KelleyBoard Member
Sabrina Martucci JohnsonSabrina Martucci JohnsonBoard Member
Jessica GrossmanJessica GrossmanBoard Member
Cheryl Renee BlanchardCheryl Renee BlanchardBoard Member
Roger HawleyRoger HawleyCo-Founder
Regulus Therapeutics
Regulus Therapeutics
Public$380.9M302007San Diego, CA, US
Board Member· Board

Leadership at Regulus Therapeutics

Kathryn J CollierKathryn J CollierBoard Member
Simos SimeonidisSimos SimeonidisBoard Member
Pascale WitzPascale WitzBoard Member
Stelios PapadopoulosStelios PapadopoulosBoard Member
Jay HaganJay HaganBoard Member
Jake NunnJake NunnBoard Member

Similar to Regulus Therapeutics

Regel TherapeuticsRegel TherapeuticsBoston, MA, USGene TherapyRegel TherapeuticsBoston, MA, US

Regel Therapeutics: Revolutionizing gene therapy and transforming patient outcomes with unique technology.

Pre-Seed · $1M14
Regor TherapeuticsRegor TherapeuticsBoston, MA, USBiotechnologyest. 2018Regor TherapeuticsBoston, MA, US · est. 2018

Regor: A global biotech leader innovating in oncology, metabolic and autoimmune diseases.

Series D · $140M8
Regulonix HoldingRegulonix HoldingTucson, AZ, USPain Treatmentsest. 2017Regulonix HoldingTucson, AZ, US · est. 2017

Regulonix: A biotech firm innovating non-opioid, chronic pain treatments via NaV1.7 channel targeting.

Seed · $2M8
Ionis PharmaceuticalsIonis PharmaceuticalsCarlsbad, CA, USPharmaceuticalsest. 1989Ionis PharmaceuticalsCarlsbad, CA, US · est. 1989

Ionis Pharmaceuticals: A US-based biotech firm specializing in RNA-targeted drug discovery for unmet needs.

Public · $1.3B796
Neurocrine B
Neurocrine B
Public$260M1.2k1992San Diego, CA, US
Board Member· Board

Leadership at Neurocrine B

Gary LyonsGary LyonsBoard Member
Richard F. PopsRichard F. PopsBoard Member
Errol De SouzaErrol De SouzaCo-Founder
Wylie ValeWylie ValeCo-Founder
Larry BockLarry BockCo-Founder
Leslie V. NorwalkLeslie V. NorwalkBoard Member

Similar to Neurocrine B

Crinetics PharmaceuticalsCrinetics PharmaceuticalsSan Diego, CA, USTherapeuticsest. 2008Crinetics PharmaceuticalsSan Diego, CA, US · est. 2008

San Diego-based Crinetics Pharmaceuticals develops therapeutics for endocrine diseases and cancers.

Public · $796M210
NeurolixisNeurolixisSan Diego, CA, USPharmaceuticalsest. 2011NeurolixisSan Diego, CA, US · est. 2011

San Diego-based Neurolixis, a biopharmaceutical firm innovating treatments for central nervous system diseases.

Seed · $15k6
NeuroTherapeutics PharmaNeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30
SynchroneuronSynchroneuronWaltham, MA, USBiopharmaceuticalsest. 2011SynchroneuronWaltham, MA, US · est. 2011

Synchroneuron Inc. develops innovative biopharmaceuticals for tardive dyskinesia and related disorders.

Public · $26M7
GRAIL
GRAIL
Public$2B8232016Menlo Park, CA, US
Board Member· Board

Recent news

Littlebird raises $11M for its AI-assisted ‘recall’ tool that reads your computer screenTechCrunch · 2026

Leadership at GRAIL

George GolumbeskiGeorge GolumbeskiBoard Member
Brook ByersBrook ByersBoard Member
Jeff DeanJeff DeanBoard Member
Jeff HuberJeff HuberBoard Member
Bob RagusaBob RagusaCEO
Maykin HoMaykin HoBoard Member

Similar to GRAIL

FreenomeFreenomeSouth San Francisco, CA, USCancer Detectionest. 2014FreenomeSouth San Francisco, CA, US · est. 2014

Freenome, a US-based company, is dedicated to providing tools for cancer detection, treatment, and prevention.

Late Stage Private · $1.1B375
Guardant HealthGuardant HealthPalo Alto, CA, USCancer Diagnosticsest. 2011Guardant HealthPalo Alto, CA, US · est. 2011

Guardant Health: A Palo Alto-based biotech firm providing global cancer diagnostics and sequencing services.

Public1.8k
Thrive Earlier DetectionThrive Earlier DetectionCambridge, MA, USCancer Detectionest. 2019Thrive Earlier DetectionCambridge, MA, US · est. 2019

Thrive, a healthcare company, pioneers in early cancer detection through its innovative test, CancerSEEK.

Late Stage Private · $367M175
Exact SciencesExact SciencesMadison, WI, USCancer Diagnosticsest. 1995Exact SciencesMadison, WI, US · est. 1995

Exact Sciences Corp., a US-based firm, develops non-invasive tests for early colorectal cancer detection.

Public · $2.1B6.4k

William H. Rastetter's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to William H. Rastetter

Caley CasteleinCaley CasteleinFounder · Kearny Venture PartnersBob MoreBob MoreBoard Member · Nuon TherapeuticsBob RosenthalBob RosenthalBoard Member · Bruker BioSpinRobin SteeleRobin SteeleBoard Member · Alveo TechnologiesGrace ColónGrace ColónBoard Member · CareDx